Scientists have identified a protective brain pathway that may help slow the progression of Parkinson's disease by ...
This continuing education course details the role of GLP-1 injectables in managing chronic conditions and overweight/obesity, ...
GLP-1 weight-loss drugs alter brain circuits in the amygdala and dopamine system to reduce the motivation to seek out high-calorie foods.
A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does more than suppress appetite-it directly alters brain circuits that control motivation and reward.
The rising prevalence of diseases in both developed and developing nations highlights the need to explore new pharmaceutical ...
Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor ...
A new Texas A&M study identifies NR4A1 as one possible pathway through which coffee compounds may influence health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results